This is the authors' abstract. We don't add key points for this paper.
Chlamydia trachomatis is a global health burden due to its prevalence as a sexually transmitted disease and as the causative agent of the eye infection trachoma. We recently discovered 3-amido thiazolino 2-pyridones which attenuated C. trachomatis infectivity without affecting host cell or commensal bacteria viability. We present here the synthesis and evaluation of nonhydrolyzable amide isosteres based on this class, leading to highly potent 1,2,3-triazole based infectivity inhibitors (EC 50 ≤ 20 nM).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Good et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: